The 3D printing in healthcare market size has grown rapidly in recent years. It will grow from $2.47 billion in 2025 to $2.95 billion in 2026 at a compound annual growth rate (CAGR) of 19.3%. The growth in the historic period can be attributed to advancements in additive manufacturing technologies, early adoption of 3D printed surgical guides, expansion of academic research in medical printing, increased use of anatomical modeling, availability of diverse printable biomaterials.
The 3D printing in healthcare market size is expected to see rapid growth in the next few years. It will grow to $5.99 billion in 2030 at a compound annual growth rate (CAGR) of 19.4%. The growth in the forecast period can be attributed to increasing investments in bioprinting research, rising demand for personalized healthcare solutions, expansion of regenerative medicine applications, growing adoption of point-of-care manufacturing, increasing regulatory approvals for printed medical devices. Major trends in the forecast period include increasing adoption of patient-specific medical devices, rising use of bioprinting technologies, growing demand for customized surgical models, expansion of 3D printed implants and prosthetics, enhanced integration of digital design and manufacturing.
The increasing prevalence of chronic diseases is anticipated to drive the growth of the 3D printing market in the coming years. Chronic diseases are long-lasting health conditions that are typically persistent and often incurable, including disorders such as diabetes, hypertension, and arthritis. The growing burden of these conditions is largely attributed to the widespread adoption of modifiable lifestyle risk factors, including sedentary behavior, diets rich in processed foods, and high consumption of tobacco and alcohol. Three-dimensional printing supports the development of customized medical devices and implants for chronic disease management, improving treatment outcomes through highly personalized and precise solutions. For instance, in February 2024, data from the Centers for Disease Control and Prevention indicated that in 2023, approximately 129 million people in the United States were living with at least one major chronic disease, such as heart disease, cancer, diabetes, obesity, or hypertension. Among them, 42% had two or more chronic conditions and 12% had at least five conditions, while nearly 90% of the annual USD 4.1 trillion healthcare expenditure was associated with the treatment and management of chronic diseases and mental health conditions. Therefore, the rising incidence of chronic diseases is contributing significantly to the expansion of the 3D printing market.
Leading companies operating in the 3D printing in healthcare space are prioritizing technological advancements such as multi-material 3D printing, which enables the production of complex, patient-specific medical and dental solutions with enhanced precision, efficiency, and aesthetic quality. Multi-material 3D printing refers to a manufacturing process that allows the simultaneous use of two or more materials within a single print, supporting the creation of highly functional and customized components in one build cycle. For example, in July 2024, Stratasys Ltd. launched the DentaJet XL, a high-speed PolyJet 3D printer designed specifically for digital dental laboratories. Equipped with a large build tray and 4-kilogram hot-swap resin cartridges, the system enables continuous production of up to 102 crowns and bridges in a single run. Its super high-speed mode increases productivity by up to 50%, while dual-material printing capabilities support the fabrication of multi-component dental restorations simultaneously. In addition, integrated software automates part layout and large-batch post-processing, reducing labor requirements and operational costs while improving accuracy, throughput, and safety in high-volume dental manufacturing environments.
In July 2024, Materialise, a Belgium-based provider of 3D printing solutions, acquired FEops for an undisclosed amount. This acquisition will allow the company to enhance its cardiovascular solutions by incorporating predictive simulation capabilities powered by 3D technologies. This advancement aims to support the development of personalized treatments for heart disease, customized to each patient's unique anatomy, ultimately leading to improved outcomes and patient satisfaction. FEops specializes in simulation technology, providing software solutions for engineering simulation and analysis, and is also a Belgium-based company that offers 3D printing solutions in the healthcare sector, particularly in cardiovascular care.
Major companies operating in the 3D printing in healthcare market are Hewlett-Packard Company, Stratasys Ltd., EOS GmbH - Electro Optical Systems, 3D Systems Corporation, Formlabs Inc., Materialise NV, Ultimaker BV, SLM Solutions Group AG, Arcam AB, The ExOne Company, EnvisionTEC GmbH, Concept Laser GmbH, MedPrin Regenerative Medical Technologies Co. Ltd., Medical Molding Inc., Nanoscribe GmbH & Co. KG, Oxford Performance Materials Inc., Aspect Biosystems Ltd., Cyfuse Biomedical K.K., Anatomics Pty. Ltd., Organovo Holdings Inc, 3D Bioprinting Solutions, Allevi Inc.
North America was the largest region in the 3D printing in healthcare market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the 3D printing in healthcare market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the 3D printing in healthcare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the 3D printing in healthcare market by increasing costs of imported printers, lasers, electronic control systems, and specialized printing materials such as metals and biomaterials. Medical device manufacturers and research institutions in North America and Europe are most affected due to dependence on imported high-precision systems, while Asia-Pacific faces higher material and equipment costs. These tariffs are raising capital investment requirements and slowing adoption in smaller facilities. At the same time, they are promoting domestic printer manufacturing, local material development, and regional innovation ecosystems for healthcare additive manufacturing.
The 3D printing in healthcare market research report is one of a series of new reports that provides 3D printing in healthcare market statistics, including 3D printing in healthcare industry global market size, regional shares, competitors with a 3D printing in healthcare market share, detailed 3D printing in healthcare market segments, market trends and opportunities, and any further data you may need to thrive in the 3D printing in healthcare industry. This 3D printing in healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The application of 3D printing in the healthcare sector entails producing a three-dimensional object by layering materials according to a digital design customized for healthcare purposes. This involves utilizing 3D design and printing technologies to create medical devices tailored to individual patients, anatomical models, and surgical tools.
The primary components of 3D printing in healthcare encompass systems, materials, and services. The provision of 3D printing services facilitates specialists in generating reference models through the utilization of MRI scans and CT scans, assisting surgeons in their preparations for surgeries. A range of technologies, including laser beam melting (LBM), electron beam melting (EBM), photopolymerization, droplet deposition, laminated object manufacturing, wax deposition modeling, and bio printing, contribute to this field. These technologies find diverse applications, such as creating personalized medical equipment, developing models for surgical planning and education, producing prosthetics and implants, advancing biomaterials, and printing personalized medicine. Moreover, these technologies are employed by various end users, including medical and surgical centers, pharmaceutical and biotechnology companies, and academic institutions.
The 3D printing in the healthcare market consists of revenues earned by entities by providing tailored medical solutions, and surgical training. The market value includes the value of related goods sold by the service provider or included within the service offering. The 3D printing in the healthcare market also includes sales of patient-specific prosthetics and orthopedic implants. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The 3D printing in healthcare market size is expected to see rapid growth in the next few years. It will grow to $5.99 billion in 2030 at a compound annual growth rate (CAGR) of 19.4%. The growth in the forecast period can be attributed to increasing investments in bioprinting research, rising demand for personalized healthcare solutions, expansion of regenerative medicine applications, growing adoption of point-of-care manufacturing, increasing regulatory approvals for printed medical devices. Major trends in the forecast period include increasing adoption of patient-specific medical devices, rising use of bioprinting technologies, growing demand for customized surgical models, expansion of 3D printed implants and prosthetics, enhanced integration of digital design and manufacturing.
The increasing prevalence of chronic diseases is anticipated to drive the growth of the 3D printing market in the coming years. Chronic diseases are long-lasting health conditions that are typically persistent and often incurable, including disorders such as diabetes, hypertension, and arthritis. The growing burden of these conditions is largely attributed to the widespread adoption of modifiable lifestyle risk factors, including sedentary behavior, diets rich in processed foods, and high consumption of tobacco and alcohol. Three-dimensional printing supports the development of customized medical devices and implants for chronic disease management, improving treatment outcomes through highly personalized and precise solutions. For instance, in February 2024, data from the Centers for Disease Control and Prevention indicated that in 2023, approximately 129 million people in the United States were living with at least one major chronic disease, such as heart disease, cancer, diabetes, obesity, or hypertension. Among them, 42% had two or more chronic conditions and 12% had at least five conditions, while nearly 90% of the annual USD 4.1 trillion healthcare expenditure was associated with the treatment and management of chronic diseases and mental health conditions. Therefore, the rising incidence of chronic diseases is contributing significantly to the expansion of the 3D printing market.
Leading companies operating in the 3D printing in healthcare space are prioritizing technological advancements such as multi-material 3D printing, which enables the production of complex, patient-specific medical and dental solutions with enhanced precision, efficiency, and aesthetic quality. Multi-material 3D printing refers to a manufacturing process that allows the simultaneous use of two or more materials within a single print, supporting the creation of highly functional and customized components in one build cycle. For example, in July 2024, Stratasys Ltd. launched the DentaJet XL, a high-speed PolyJet 3D printer designed specifically for digital dental laboratories. Equipped with a large build tray and 4-kilogram hot-swap resin cartridges, the system enables continuous production of up to 102 crowns and bridges in a single run. Its super high-speed mode increases productivity by up to 50%, while dual-material printing capabilities support the fabrication of multi-component dental restorations simultaneously. In addition, integrated software automates part layout and large-batch post-processing, reducing labor requirements and operational costs while improving accuracy, throughput, and safety in high-volume dental manufacturing environments.
In July 2024, Materialise, a Belgium-based provider of 3D printing solutions, acquired FEops for an undisclosed amount. This acquisition will allow the company to enhance its cardiovascular solutions by incorporating predictive simulation capabilities powered by 3D technologies. This advancement aims to support the development of personalized treatments for heart disease, customized to each patient's unique anatomy, ultimately leading to improved outcomes and patient satisfaction. FEops specializes in simulation technology, providing software solutions for engineering simulation and analysis, and is also a Belgium-based company that offers 3D printing solutions in the healthcare sector, particularly in cardiovascular care.
Major companies operating in the 3D printing in healthcare market are Hewlett-Packard Company, Stratasys Ltd., EOS GmbH - Electro Optical Systems, 3D Systems Corporation, Formlabs Inc., Materialise NV, Ultimaker BV, SLM Solutions Group AG, Arcam AB, The ExOne Company, EnvisionTEC GmbH, Concept Laser GmbH, MedPrin Regenerative Medical Technologies Co. Ltd., Medical Molding Inc., Nanoscribe GmbH & Co. KG, Oxford Performance Materials Inc., Aspect Biosystems Ltd., Cyfuse Biomedical K.K., Anatomics Pty. Ltd., Organovo Holdings Inc, 3D Bioprinting Solutions, Allevi Inc.
North America was the largest region in the 3D printing in healthcare market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the 3D printing in healthcare market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the 3D printing in healthcare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the 3D printing in healthcare market by increasing costs of imported printers, lasers, electronic control systems, and specialized printing materials such as metals and biomaterials. Medical device manufacturers and research institutions in North America and Europe are most affected due to dependence on imported high-precision systems, while Asia-Pacific faces higher material and equipment costs. These tariffs are raising capital investment requirements and slowing adoption in smaller facilities. At the same time, they are promoting domestic printer manufacturing, local material development, and regional innovation ecosystems for healthcare additive manufacturing.
The 3D printing in healthcare market research report is one of a series of new reports that provides 3D printing in healthcare market statistics, including 3D printing in healthcare industry global market size, regional shares, competitors with a 3D printing in healthcare market share, detailed 3D printing in healthcare market segments, market trends and opportunities, and any further data you may need to thrive in the 3D printing in healthcare industry. This 3D printing in healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The application of 3D printing in the healthcare sector entails producing a three-dimensional object by layering materials according to a digital design customized for healthcare purposes. This involves utilizing 3D design and printing technologies to create medical devices tailored to individual patients, anatomical models, and surgical tools.
The primary components of 3D printing in healthcare encompass systems, materials, and services. The provision of 3D printing services facilitates specialists in generating reference models through the utilization of MRI scans and CT scans, assisting surgeons in their preparations for surgeries. A range of technologies, including laser beam melting (LBM), electron beam melting (EBM), photopolymerization, droplet deposition, laminated object manufacturing, wax deposition modeling, and bio printing, contribute to this field. These technologies find diverse applications, such as creating personalized medical equipment, developing models for surgical planning and education, producing prosthetics and implants, advancing biomaterials, and printing personalized medicine. Moreover, these technologies are employed by various end users, including medical and surgical centers, pharmaceutical and biotechnology companies, and academic institutions.
The 3D printing in the healthcare market consists of revenues earned by entities by providing tailored medical solutions, and surgical training. The market value includes the value of related goods sold by the service provider or included within the service offering. The 3D printing in the healthcare market also includes sales of patient-specific prosthetics and orthopedic implants. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. 3D Printing in Healthcare Market Characteristics
3. 3D Printing in Healthcare Market Supply Chain Analysis
4. Global 3D Printing in Healthcare Market Trends and Strategies
5. 3D Printing in Healthcare Market Analysis of End Use Industries
7. Global 3D Printing in Healthcare Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global 3D Printing in Healthcare Total Addressable Market (TAM) Analysis for the Market
9. 3D Printing in Healthcare Market Segmentation
10. 3D Printing in Healthcare Market Regional and Country Analysis
11. Asia-Pacific 3D Printing in Healthcare Market
12. China 3D Printing in Healthcare Market
13. India 3D Printing in Healthcare Market
14. Japan 3D Printing in Healthcare Market
15. Australia 3D Printing in Healthcare Market
16. Indonesia 3D Printing in Healthcare Market
17. South Korea 3D Printing in Healthcare Market
18. Taiwan 3D Printing in Healthcare Market
19. South East Asia 3D Printing in Healthcare Market
20. Western Europe 3D Printing in Healthcare Market
21. UK 3D Printing in Healthcare Market
22. Germany 3D Printing in Healthcare Market
23. France 3D Printing in Healthcare Market
24. Italy 3D Printing in Healthcare Market
25. Spain 3D Printing in Healthcare Market
26. Eastern Europe 3D Printing in Healthcare Market
27. Russia 3D Printing in Healthcare Market
28. North America 3D Printing in Healthcare Market
29. USA 3D Printing in Healthcare Market
30. Canada 3D Printing in Healthcare Market
31. South America 3D Printing in Healthcare Market
32. Brazil 3D Printing in Healthcare Market
33. Middle East 3D Printing in Healthcare Market
34. Africa 3D Printing in Healthcare Market
36. 3D Printing in Healthcare Market Competitive Landscape and Company Profiles
37. 3D Printing in Healthcare Market Other Major and Innovative Companies
40. 3D Printing in Healthcare Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
3D Printing In Healthcare Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses 3d printing in healthcare market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for 3d printing in healthcare? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The 3d printing in healthcare market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Component: System; Material; Services2) By Technology: Laser Beam Melting (LBM); Electron Beam Melting (EBM); Photo Polymerization; Droplet Deposition; Laminated Object Manufacturing; Wax Deposition Modeling; Bio Printing
3) By Application: Personalized Medical Equipment; Models For Surgical Planning And Education; Prosthetics And Implants; Biomaterials; Printing Personalized Medicine; Other Applications
4) By End User: Medical And Surgical Centers; Pharmaceutical And Biotechnology Companies; Academic Institutions
Subsegments:
1) By System: 3D Printers; 3D Bioprinters; Scanners; Other Systems.2) By Material: Plastics; Metals; Ceramics; Biomaterials; Other Materials.
3) By Services: Custom Prosthetics; Implants; Surgical Guides; Medical Device Prototyping; Tissue Engineering.
Companies Mentioned: Hewlett-Packard Company; Stratasys Ltd.; EOS GmbH - Electro Optical Systems; 3D Systems Corporation; Formlabs Inc.; Materialise NV; Ultimaker BV; SLM Solutions Group AG; Arcam AB; The ExOne Company; EnvisionTEC GmbH; Concept Laser GmbH; MedPrin Regenerative Medical Technologies Co. Ltd.; Medical Molding Inc.; Nanoscribe GmbH & Co. KG; Oxford Performance Materials Inc.; Aspect Biosystems Ltd.; Cyfuse Biomedical K.K.; Anatomics Pty. Ltd.; Organovo Holdings Inc; 3D Bioprinting Solutions; Allevi Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this 3D Printing in Healthcare market report include:- Hewlett-Packard Company
- Stratasys Ltd.
- EOS GmbH - Electro Optical Systems
- 3D Systems Corporation
- Formlabs Inc.
- Materialise NV
- Ultimaker BV
- SLM Solutions Group AG
- Arcam AB
- The ExOne Company
- EnvisionTEC GmbH
- Concept Laser GmbH
- MedPrin Regenerative Medical Technologies Co. Ltd.
- Medical Molding Inc.
- Nanoscribe GmbH & Co. KG
- Oxford Performance Materials Inc.
- Aspect Biosystems Ltd.
- Cyfuse Biomedical K.K.
- Anatomics Pty. Ltd.
- Organovo Holdings Inc
- 3D Bioprinting Solutions
- Allevi Inc
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.95 Billion |
| Forecasted Market Value ( USD | $ 5.99 Billion |
| Compound Annual Growth Rate | 19.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
